Literature DB >> 12493008

The immunogenomics of minor histocompatibility antigens.

Derry Roopenian1, Eun Young Choi, Aaron Brown.   

Abstract

Minor histocompatibility (H) antigens are a diverse assemblage of major histocompatibility complex (MHC)-bound peptides with the unifying property of acting as alloantigens that induce allogeneic tissue rejection. They are a consequence of any form of accumulated genetic variation that translates to differential MHC-presented peptide epitopes, the most common form of which is simple sequence polymorphisms. The universe of potential minor H antigens is large when transplantation is performed between genetically unrelated, MHC-matched individuals, especially considering the remarkable discriminative sensitivity of T cells. However, the phenomenon of immunodominance greatly simplifies immune responses that ensue. One mouse minor H antigen, H60, stands out in that the preponderance of the CD8 T cell response elicited in a complex alloantigenic setting is directed against this single minor H antigen epitope. Its immunodominance is because mice lacking H60 develop an unusually robust T cell repertoire dedicated to this single minor H antigen. The now well-characterized mouse minor H antigen system should provide a vehicle to assess the degree to which immunodominant alloantigens contribute to transplant rejection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12493008     DOI: 10.1034/j.1600-065x.2002.19007.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  48 in total

1.  Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect.

Authors:  Masahiro Hirayama; Eiichi Azuma
Journal:  Chimerism       Date:  2011-01

2.  A single-amino-acid variant of the H60 CD8 epitope generates specific immunity with diverse TCR recruitment.

Authors:  Su Jeong Ryu; Ji Yeong Jeon; Jun Chang; Thomas J Sproule; Derry C Roopenian; Eun Young Choi
Journal:  Mol Cells       Date:  2012-03-21       Impact factor: 5.034

3.  Social discrimination by quantitative assessment of immunogenetic similarity.

Authors:  Jandouwe Villinger; Bruce Waldman
Journal:  Proc Biol Sci       Date:  2012-09-05       Impact factor: 5.349

4.  A novel approach to measuring cell-mediated lympholysis using quantitative flow and imaging cytometry.

Authors:  G M La Muraglia; M J O'Neil; M L Madariaga; S G Michel; K S Mordecai; J S Allan; J C Madsen; I M Hanekamp; F I Preffer
Journal:  J Immunol Methods       Date:  2015-10-26       Impact factor: 2.303

5.  Tolerance induction using nanoparticles bearing HY peptides in bone marrow transplantation.

Authors:  Kelan A Hlavaty; Derrick P McCarthy; Eiji Saito; Woon Teck Yap; Stephen D Miller; Lonnie D Shea
Journal:  Biomaterials       Date:  2015-10-21       Impact factor: 12.479

6.  Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donors.

Authors:  David B Miklos; Haesook T Kim; Emmanuel Zorn; Ephraim P Hochberg; Luxuan Guo; Alex Mattes-Ritz; Sebastien Viatte; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2003-09-25       Impact factor: 22.113

Review 7.  Transfusion-induced bone marrow transplant rejection due to minor histocompatibility antigens.

Authors:  Seema R Patel; James C Zimring
Journal:  Transfus Med Rev       Date:  2013-10-03

Review 8.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

9.  A methods paper that led to much more.

Authors:  Derry Roopenian
Journal:  J Immunol       Date:  2014-01-01       Impact factor: 5.422

Review 10.  Immunogenicity of pluripotent stem cells and their derivatives.

Authors:  Patricia E de Almeida; Julia D Ransohoff; Abu Nahid; Joseph C Wu
Journal:  Circ Res       Date:  2013-02-01       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.